Rosuvastatin Calcium Tablet
Product Images NDC 72603-367

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Rosuvastatin Calcium (NDC 72603-367). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rx, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (Rosuvastatin Tablets 10mg 1000s Bottle Label)

This text contains information about Rosuvastatin Tablets, USP, with each tablet containing osuvastatin calcium equivalent. The usual dosage instructions are not given in this text, and it is advised to refer to the accompanying Prescribing Information. The warning provided is to keep the medication out of reach of children. These tablets should be stored at controlled room temperature, with excursions permitted between 15°C to 30°C (59°F and 86°F), and protected from moisture. The product is dated November 25, 2000, and manufactured by Umedica Laboratories Pvt. Ltd. in Vapi, Gujarat, India, for Northstar Rx LLC in Memphis, TN.*

FDA Label Image

Image Description (Rosuvastatin Tablets 10mg 90s Bottle Label)

This is a product information sheet for tablets containing Rosuvastatin calcium, manufactured by S Umedica Laboratories Pvt. Ltd. and Northstar Rx LLC in India. The tablets are used to lower cholesterol levels. The usual dosage and storage information are provided, along with a warning to keep the tablets out of reach of children. The sheet also includes the NDC number and manufacturing details.*

FDA Label Image

Image Description (Rosuvastatin Tablets 20mg 1000s Bottle Label)

This is information about Rosuvastatin tablets, USP in a pack of 1000 tablets, each containing 20 mg of Rosuvastatin. The usual dosage information is available in the accompanying prescribing information. It is important to keep this medication out of the reach of children and store it at a controlled room temperature between 20°C to 25°C (68°F to 77°F), with excursions permitted between 15°C and 30°C (59°F and 86°F). This product is manufactured in India by Umedica Laboratories Pvt. Ltd. for Northstar Rx LLC based in Memphis, TN. Please refer to the packaging for more details.*

FDA Label Image

Image Description (Rosuvastatin Tablets 20mg 500s Bottle Label)

FDA Label Image

Image Description (Rosuvastatin Tablets 20mg 90s Bottle Label)

This is a description for Rosuvastatin calcium tablets, each containing 20 mg of Rosuvastatin USP. The usual dosage information can be found in the accompanying Prescribing Information. The tablets should be stored at a controlled room temperature between 20°C to 25°C, with excursions permitted between 15°C and 30°C. It is important to protect the tablets from moisture. The manufacturer is Umedica Laboratories Pvt. Ltd, based in Vapi, Gujarat, India. The tablets are manufactured for Northstar Rx LLC in Memphis, TN.*

FDA Label Image

Image Description (Rosuvastatin Tablets 40mg 1000s Bottle Label)

Each tablet of this medication contains 40 mg of Rosuvastatin calcium USP. It is advised to store the tablets at room temperature and protect from moisture. The product is manufactured in India by Umedica Laboratories Pvt. Ltd. for Northstar Rx LLC in Memphis, TN. This medication is prescribed and should be kept out of reach of children.*

FDA Label Image

Image Description (Rosuvastatin Tablets 40mg 30s Bottle Label)

The provided text contains information about a tablet containing Rosuvastatin calcium USP equivalent to 40mg of Rosuvastatin. It is manufactured by Umedica Laboratories Pvt. Ltd. for Northstar Rx LLC in India. The usual dosage instructions and storage recommendations are also included. This tablet is part of a package containing 30 tablets.*

FDA Label Image

Image Description (Rosuvastatin Tablets 40mg 500s Bottle Label)

This is a description of Rosuvastatin tablets in a packaging containing 500 tablets. Each tablet contains 40 mg of Rosuvastatin calcium. The usual dosage instructions are provided in the accompanying Prescribing Information. The medication should be stored at a controlled room temperature between 20°C to 25°C (68°F to 77°F), with excursions permitted between 15°C and 30°C (59°F and 86°F). The product is manufactured in India by Umedica Laboratories Pvt. Ltd. for Northstar Rx LLC, based in Memphis, TN. It is important to keep this medication out of the reach of children and protect it from moisture.*

FDA Label Image

Image Description (Rosuvastatin Tablets 40mg 90s Bottle Label)

This is a description of a medication containing Rosuvastatin calcium. Each tablet has 40mg of Rosuvastatin and is manufactured by Umedica Laboratories Pvt. Ltd. in India for Northstar Rx LLC in Tennessee, USA. The usual dosage should be followed as per the prescribing information. The tablets should be stored at room temperature between 20°C to 25°C and protected from moisture. The NDC code for the medication is 72603-367-02.*

FDA Label Image

Image Description (Rosuvastatin Tablets 5mg 1000s Bottle Label)

This text provides information about a medication called Roswasan T, which contains Rosuvastatin calcium USP. The usual dosage instructions and storage guidelines are given. The tablets are manufactured in India by Umedica Laboratories Pvt. Ltd. for Northstar Rx LLC.*

FDA Label Image

Image Description (Rosuvastatin Tablets 5mg 90s Bottle Label)

This text provides information about Rosuvastatin tablets containing 5mg of Rosuvastatin calcium. The tablets are recommended to be stored at a controlled room temperature. The medication should be kept out of reach of children, and users are advised to refer to the prescribing information for proper dosage. The product is manufactured by Umedica Laboratories Pvt. Ltd. in India for Northstar Rx LLC in Memphis, TN.*

FDA Label Image

Figure_1_time_jupiter (Rosuvastatin Tablets Figure 1)

This text provides hazard ratio (HR) of 0.56 with a 95% confidence interval of 0.46-0.69 and a statistically significant p-value of less than 0.001. It also includes cumulative incidence data, number at risk, and years for two groups: RSV and Placebo.*

FDA Label Image

Figure_2-major_jupiter (Rosuvastatin Tablets Figure 2)

This data presents the results of a study comparing the effects of Rosuva 20 mg versus Placebo 20 mg on various endpoints. The study involved 8901 participants and evaluated different events such as the primary endpoint (MCE), cardiovascular death, nonfatal stroke, nonfatal MI, atrial fibrillation, and arterial revascularization. The Hazard Ratios with confidence intervals and p-values are provided for each endpoint, showing the impact of the treatments on these events. The results suggest that Rosuva 20 mg may have a significant benefit compared to Placebo 20 mg in reducing the risk of cardiovascular events such as nonfatal stroke and nonfatal MI.*

FDA Label Image

Figure_3_percent_dyslipidemia (Rosuvastatin Tablets Figure 3)

FDA Label Image

Structural_formula (Rosuvastatin Tablets Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.